Clinical Drug Experience Knowledgebase

capecitabine (xeloda) (11 trials)

epirubicin (ellence) (15 trials)

exemestane (aromasin) (4 trials)

fulvestrant (faslodex) (4 trials)

letrozole (femara) (4 trials)

paclitaxel (taxol) (19 trials)

palbociclib (ibrance) (3 trials)

tamoxifen (nolvadex) (5 trials)

vinorelbine (navelbine) (2 trials)

anastrozole (arimidex) (2 trials)

bevacizumab (avastin) (4 trials)

carboplatin (paraplatin) (6 trials)

cisplatin (platinol) (1 trial)

cyclophosphamide (cytoxan) (16 trials)

darbepoetin alfa (aranesp) (1 trial)

docetaxel (taxotere) (8 trials)

doxorubicin (Doxil) (5 trials)

everolimus (zortress) (4 trials)

fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)

ferric carboxymaltose (Injectafer) (1 trial)

fluorouracil (efudex) (4 trials)

goserelin (zoladex) (2 trials)

ibandronate (boniva) (2 trials)

lapatinib (tykerb) (3 trials)

leuprolide (lupron) (1 trial)

naltrexone (revia) (2 trials)

pertuzumab (perjeta) (4 trials)

sacituzumab govitecan (Trodelvy) (1 trial)

sodium chloride (1 trial)

tacrolimus (prograf) (1 trial)

trastuzumab (herceptin) (12 trials)

trastuzumab emtansine (kadcyla) (2 trials)

veliparib (1 trial)

zoledronic acid (zometa) (1 trial)

afatinib (gilotrif) (1 trial)

buparlisib (1 trial)

cabazitaxel (jevtana kit) (1 trial)

denosumab (prolia) (1 trial)

durvalumab (imfinzi) (1 trial)

eribulin (halaven) (1 trial)

gdc-0077 (1 trial)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

ribociclib (kisqali) (1 trial)

sorafenib (nexavar) (1 trial)

bendamustine (treanda) (1 trial)

pazopanib (votrient) (1 trial)